What is Bio-Rad Laboratories's treasury stock?

Bio-Rad Laboratories (BIO) reported treasury stock of $1.01B in Q4 2025.

What is the long-term trend for Bio-Rad Laboratories's treasury stock?

Over 3 years (2022 to 2025), Bio-Rad Laboratories's treasury stock has grown at a 56.5% compound annual growth rate (CAGR), from $263.59M to $1.01B.

Bio-Rad Laboratories BIO Treasury Stock

Treasury Stock at other companies

AbbottABT

$16.94B+1.9%

Thermo Fisher ScientificTMO

$25.36B+19.2%

DanaherDHR

$11.41B+22.6%

Charles River LaboratoriesCRL

$209.99M-41.1%

Quest DiagnosticsDGX

$5.09B+6.3%

WAT

Waters CorporationWAT

$10.17B+0.1%

Other financials

Income statement

See full

Revenue$592.1M+1.1%

Gross profit$309.4M+1.1%

Operating income$34.1M+43.9%

Net income-$527.1M-924%

EPS (diluted)-$19.55-954%

Balance sheet

See full

Cash & equivalents$509.0M-2.7%

Total debt$987.3M-28.4%

Total equity$6.9B+2.6%

Total assets$9.8B+2.8%

Cash flow

See full

Operating cash flow$108.1M-16.8%

CapEx$30.0M-12.8%

Free cash flow$78.1M-18.2%

Valuation

See full

Market cap$7.56B+10.3%

Enterprise value$8.04B+4.2%

P/E44.8×—

P/S2.9×+0.2×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin8.8%-3.1pp

Net margin6.5%+3.4pp

FCF margin13.8%-0.2pp

Returns & leverage

See full

Return on equity2.5%+1.3pp

Debt / equity0.1×-0.1×

Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockValue.

The official record: Bio-Rad Laboratories’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Rad Laboratories's treasury stock?: Bio-Rad Laboratories (BIO) reported treasury stock of $1.01B in Q4 2025.
What is the long-term trend for Bio-Rad Laboratories's treasury stock?: Over 3 years (2022 to 2025), Bio-Rad Laboratories's treasury stock has grown at a 56.5% compound annual growth rate (CAGR), from $263.59M to $1.01B.